baber/WOPTO huggingface dataset:
Patent NZ-281871-A (NZ)
Title: Apparatus for ultrasonic bone treatment
Inventor: TALISH ROGER J
IPC: A61B17/225
Filed: 1995-03-02
Abstract: The apparatus is used for therapeutically treating injuries using ultrasound. The apparatus includes an ergonomically constructed ultrasonic transducer treatment head module partially fabricated with a conductive plastic material. The apparatus also utilizes a portable, ergonomically constructed main operating unit constructed to fit within a pouch worn by the patient. In operation, the transducer treatment head module is positioned adjacent the area of the injury and excited for a predetermined period of time. To ensure that the transducer treatment head module is properly positioned, and to insure compliance with a treatment protocol, a safety interlock is provided to prevent inadvertent excitation of the transducer.
Patent NZ-331618-A (NZ)
Title: Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
Inventor: SCHERZ MICHAEL WIARD
IPC: C07D307/79
Filed: 1997-01-30
Abstract: The specification describes a compound having structure (I) wherein n is from 1 to about 3; X is selected from the group consisting of O, S, SO, or SO2; Y is independently hydrogen or straight, branched or cyclic alkyl having from 1 to about 4 carbon atoms, or the Y's are bonded together to form an alkanyl ring having from 3 to about 7 atoms; Z is hydrogen or straight, branched or cyclic alkyl having from 3 to about 10 atoms other than hydrogen; (e) W is O or S; and R1, R2 and R3 are independently hydrogen, straight, branched or cyclic alkyl having from 1 to 10 carbon atoms, aryl, heterocyclyl, heteroaryl, hydroxy, or alkoxy; or R1, R2 or R3 may be bonded to form one or more rings each ring having from 3 to about 7 atoms wherein from 1 to 3 atoms may be heteroatoms. Pharmaceutical compositions and methods of treating inflammation or pain are disclosed.
Patent NZ-332015-A (NZ)
Title: Synergistic pesticidal compositions of cyprodinil and myclobutanil
Inventor: KNAUF BEITER GERTRUDE
IPC: A01N43/54
Filed: 1997-03-29
Abstract: A fungicidal composition having synergistic action against disease infestation in plants, comprising at least two active ingredient components together with a suitable carrier, wherein component (I) is cyprodinil [=2-anilino-4-cyclopropyl-6-methyl-pyrimidine] as depicted in (Formula (I) above. Component (II) is myclobutanil [=2-p-chlorophenyl-2-(1H-1,2,4-triazol-1-ylmethyl) hexanenitrile].
Patent NZ-332963-A (NZ)
Title: The use of one or more non-toxic polysaccharides in a temporary biocompatible glue for adhering a medical instrument onto or into a human or animal body
Inventor: JOHANSSON-RUDEN GUNILLA
IPC: C09J105/00
Filed: 1997-05-30
Abstract: Use of one or more saccharides, for example one or more non-toxic mono-, di-, tri-, oligo- or polysaccharides, in the manufacture of a biocompatible glue for adhering a first structure to a surface of a second structure. The biocompatible glue can be adapted to act as temporary glue. In this case the glue may be used to enable a medical structure to be transferred from a medical instrument onto the surface of a human or animal body, for example as in the transfer of a buffer material from the fork of a surgical stapler to a diseased lung after one or more rows of staples have been fired through the buffer material into the lung during lung volume reduction surgery for treating emphysema. The biocompatible glue can also be used to adhere or secure medical structures directly to a human or animal body, such as in the case of a patch being applied to the skin of a mammal.
Patent NZ-333202-A (NZ)
Title: Medicinal aerosol formulations of formoterol
Inventor: OLIVER MARTIN J
IPC: A61K31/167
Filed: 1997-06-02
Abstract: This pharmaceutical suspension formulation which is suitable for aerosol administration comprises: (a) 0.0025 to 0.1 % w/w of micronized Formoterol, or an acid addition salt thereof, (b) 0.1 to 5.0 % w/w ethanol (c) HFA 134a, HFA 227 or a mixture of HFA 227 and HFA 134a, and optionally (d) a surfactant other than a monoacetylated or diacetylated monoglyceride; the formulation being further characterized in that it exhibits substantially no growth in particle size or change in crystal morphology of the drug over a prolonged period, is substantially and readily redispersible, and upon redispersion does not flocculate so quickly as to prevent reproducible dosing of the drug.
Patent NZ-502966-A (NZ)
Title: Agonist of PPAR-alpha and PPAR-gamma for the manufacture of medicaments for treating Syndrome X
Inventor: SMITH STEPHEN ALISTAIR
IPC: A61K31/00
Filed: 1997-01-07
Abstract: A method of treating Syndrome X using agonists of PPARa and PPARg provided that the agonists are not clofibrate, (S)-3-[4-[2-[N-(2-benzoxazolyl)-N-methylamino]ethoxy]phenyl]-2-(2-methoxyethoxy)propanoic acid or (S)-3-[4-[2-[N-(2-benzoxazolyl)-N-methylamino]ethoxy]phenyl]-2-(2,2,2-trifluoroethoxy)propanoic acid.
Patent NZ-503963-A (NZ)
Title: 1-substituted-1-aminomethyl-cycloalkane derivatives, or gabapentin analogues, preparation and use in the treatment of neurological disorders
Inventor: BRYANS JUSTIN STEPHEN
IPC: A61K31/00
Filed: 1998-11-10
Abstract: A range of 1-substituted-aminomethyl-cycloalkane derivatives, or gabapentin analogues, are disclosed.  Such compounds are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders, especially irritable bowel syndrome.
Patent NZ-509348-A (NZ)
Title: Use of a somatostatin analogue Lanreotide
Inventor: MOREAU JACQUES-PIERRE
IPC: A61P25/28
Filed: 1999-07-29
Abstract: A use in the manufacture of a medicament of the compound H-â-D-Nal-Cys-Try-D-Trp-Lys-Val-Cys-Thr-NH2 -, to treat a disease condition selected from pancreatic psuedocysts, pancreatic ascites, nesidoblastosis, Zollinger- Ellison Syndrome, diabetic neuropathy, small bowel obstruction, cancer cachexia and other conditions.
Patent NZ-512597-A (NZ)
Title: Benzimidazole compounds and their use as active therapeutic substances
Inventor: NORIN MARTIN
IPC: C07D417/12
Filed: 2000-01-24
Abstract: A compound of formula (I), where: Y-X is >C=X or >C-X depending on the value of X; z is O, S or NR12; and all other variables are as defined in the disclosure. Also described are pharmaceutical compositions comprising the compound of formula (I). The compound of formula (I) is useful for the treatment of growth hormone deficiency, Turner syndrome, infertility, wound healing, dystrophy, osteoporosis and/or lactation failure.
Patent NZ-512803-A (NZ)
Title: Cyclic guanidine derivatives useful as pesticides
Inventor: WAGNER KLAUS
IPC: A01N43/78
Filed: 2000-01-05
Abstract: A compound of formula (I) is useful as a pesticide wherein: R1 is an optionally substituted 5 or 6 membered heterocyclic ring containing 1 to 4 nitrogen atoms and/or 1 or 2 oxygen or sulphur atoms as heteroatoms ring members where the number of heteroatoms is 1 to 4;  R2 is H or alkyl; R3 is OR4, OCOR5, OCOOR6, OCONR7R8, OSO2R9 or S(O)nR10; R4 to R6 and R10 are independently alkyl, alkoxyalkyl, haloalkyl, alkenyl, alkynyl, alkylaminoalkyl, di-alkylaminoalkyl, optionally substituted cycloalkyl, phenyl or benzyl; n is 0-2; R7 and R8 are independently H, alkyl, alkenyl, optionally substituted phenyl or benzyl; R9 is alkyl or optionally substituted phenyl; A is oxygen, sulphuric or NR11; R11 is alkyl, alkenyl, alkynyl, alkoxy or optionally substituted aralkyl and Z is cyano or nitro.
Patent NZ-514777-A (NZ)
Title: N6 heterocyclic 5'-thio substituted adenosine derivatives
Inventor: ZABLOCKI JEFF A
IPC: C07H19/167
Filed: 2000-12-01
Abstract: A N6 heterocyclic 5' modified adenosine derivative has the formula wherein: X1 is S, S(O) or S(O)2 ; R1 is a monocyclic or polycyclic heterocyclic group containing from 3 to 15 carbon atoms wherein at least one carbon atom is substituted with an atom or molecule selected from the group consisting of N, O, P and S(O)0-2 wherein R1 does not contain an epoxide group and R1 is not linked to the NH group be a heterocyclyl nitrogen atom; R2 is hydrogen, halo, CF3, or cyano; R3 and R4 are each independently hydrogen, (CO)-R', or -(CO)-R"; R' and R" are as defined in the specification; R5 is optionally substituted alkyl, alkenyl, alkynyl, heterocyclyl, aryl or heteroaryl; The compound is an adenosine A1 receptor partial or full agonist, and is useful for modifying cardiac activity, modifying adipocyte function and treating central nervous system disorders, diabetic disorders and obesity.
Patent NZ-517441-A (NZ)
Title: Heat exchangers for external combustion engine
Inventor: CLUCAS DONALD MURRAY
IPC: F02G1/055
Filed: 2002-02-26
Abstract: A recuperative heater (100) for heating the heater heads (3) of an external combustion machine (2) includes a recuperative heat exchanger having an axial pass section partially surrounding the combustion chamber (1). Combustion products pass from the recuperative heat exchanger to a condensing exhaust gas heat exchanger surrounding the axial pass section and comprising a cylindrical exhaust gas passage (15) ringed externally by a water jacket (16). Water from the water jacket (16) may be circulated to a thermal load. A top cover (17) of the heater opposes the heater heads (3) or hot end of the engine. Inner and outer plenums (6, 18) are formed between the combustion chamber wall (5) and the top cover (17) and inlet air is heated in stages as it enters the outer plenum (18), passes into the axial pass section, into the inner plenum (6), then into the combustion chamber (1).
Patent NZ-517474-A (NZ)
Title: Gypsum-rich Portland cement
Inventor: STAV ELISHA
IPC: C04B22/08
Filed: 2000-09-08
Abstract: A cementitious composition containing Ordinary Portland Cement (OPC), calcined gypsum, a source of amorphous silica and a source of amorphous alumina. The ratio of calcium sulfate hemihydrate to OPC is 0.7:1.0 to 1.8:1.0, the ratio of amorphous silica and amorphous alumina to OPC is 0.26:1.0 to 0.4:1.0, and the ratio of amorphous alumina to amorphous silica is 0.3:1.0 to 1.5:1.0. The cementitious composition, by itself and mixed with aggregates, is fast-setting and exhibits good early compressive strength and very high compressive strength after hydration. Despite the high content of calcium sulfate relative to prior art OPC formulations, the cementitious composition according to the present invention is essentially waterproof and exhibits excellent strength characteristics, even after 2 years under water. The use of calcined gypsum in place of alumina cement or even OPC is of great economic advantage, and in addition, provides the cementitious composition with quick-setting characteristics. Soluble anhydrite can replace some or all of the calcined gypsum.
Patent NZ-517821-A (NZ)
Title: Recombinant microorganisms expresssing an oligosaccharide receptor mimic
Inventor: PATON ADRIENNE
IPC: A61K35/74
Filed: 2000-09-09
Abstract: A recombinant delivery microorganism that displays on its surface a binding moiety that competes with a ligand for binding to a receptor for the ligand, when administered to an animal. The binding moiety comprises an oligosaccharide, which comprises a sugar residue that is attached to an acceptor moiety by a glycotransferase that is encoded by an exogenous nucleic acid which is present in the microorganism.
Patent NZ-518922-A (NZ)
Title: Phenalkyloxy-phenyl derivatives useful for treating conditions associated with insulin resistance
Inventor: FAGERHAG JONAS
IPC: A61K31/137
Filed: 2000-11-29
Abstract: Phneylalkyloxy-phenyl derivatives of formula (I) may be used to treat conditions associated with insulin resistance. A compound of formula (I) where: A is situated in ortho, meta and para positions and is represented by formula A(I) and A(II) where is cyano, when X is 0, and when X is 1 then R is - BRa or SCORa, where O,S, SO or SO2, where Ra represents hydrogen, alkyl, aryl or alkylaryl group is optionally substituted one or more times by Rb represents alkyl, aryl, alkylaryl, cyano, -NRcRc, =O, halogen, alkyl, aryl or alkylaryl and Rd represents alkyl, aryl or alkylaryl - BB1Ra where B1 is O when B is S, SO or SO2, or B1 is S, So or SO2 when B is O, and wherein B and Ra are defined as above. Alternatively, R is NRaRa, where each Ra is the same or different, and defined as above. R2 represents alkyl, halogen, aryl, alkylaryl, alknenyl, alkynyl (which may be optionally substituted by Rb as defined above), nitro or cyano, -BRa where B and Ra is defined above. R2 may also: - SO2NRaRf where Rf represents hydrogen, alkylacyl, aryl or alkylaryl, SO2ORa, -OCONRfRa where Rf and Ra are defined, -NRcCOORd, NRcCORa, -CONRcRa, NRcCORa, NRcSO2Rd, NRcCORNaRk (where Rk represents hydrogen, alkyl, aryl or alkylaryl). Ra, Rf, Rc, Rd are defined as above. - Alternatively, T2 is -NRcRa, where Rc and Ra are defined above. R1, R3 and R4 are the same or different and each represents hydrogen, alkyl, aryl, alkenyl, alkynyl, cyano, halogen or alkyl, where these groups may be optionally substituted by Rb. n is an integer from 1 to 6, X is an ineger 0 or 1, m is an integer 0 or 1. D is situated in ortho, meta or para positions and represents alkyl, acyl, aryl, alkylaryl, halogen or alkylaryl group is optionally substituted by Rb; - NRcCOORa, -NRcCORa, -NRcRa, -NRcSO2Rd, -NRcCONRaRk, - ORa, -OSO2Rd, -SORd, -SRc, -SO2Rd, -SORd, -SRc, -SO2NRaRf, -SO2ORa, -CONRcRa, -OCONRfRa, where Rc, Ra, Rd, Rf are defined above. D' is situated in ortho, meta or para positions and represents hydrogen, alkyl, acyl, aryl, alkylaryl, halogen, -CN, -NO2, -NRfRb, -ORf, -OSO2Rd where Rf, Rb amd Rd are defined above.
Patent NZ-523972-A (NZ)
Title: Gaming machine with multiple feature game pathways having unpredictable outcomes
Inventor: OLIVE SCOTT
IPC: G07F17/32
Filed: 2003-02-04
Abstract: A gaming machine has a display means and a game controller arranged to control images of symbols on the display means. The game controller is arranged to play a game wherein one or more random events are caused to be displayed on the display means and, if a predefined winning event occurs, the machine awards a prize. When a game played results in a feature being awarded, to arrive at a determination of a result of the feature, the control means selects a pathway having a number of steps. Each step relates to a special outcome with the number of steps taken along the pathway varying randomly from one feature to the next.
Patent NZ-525911-A (NZ)
Title: Freeze-dried pantoprazole preparation and pantoprazole injection
Inventor: LINDER RUDOLF
IPC: A61K47/02
Filed: 2001-11-17
Abstract: Process for the production of a freeze-dried preparation comprising 5-fluoromethoxy-2-[(3,4-di-methoxy-2-pyridinyl)methylsulfinyl]-1H-benzimidazole (pantoprazole), a salt, a solvate of pantoprazole or a salt thereof. This comprises freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and sodium hydroxide and/or sodium carbonate.
Patent NZ-529104-A (NZ)
Title: Prevention of epithelial cancer
Inventor: RASKOV HANS HENRIK
IPC: A61K33/06
Filed: 2002-04-05
Abstract: A combination of a cyclooxygenase inhibitor, Vitamin D3 analogue or metabolite, and calcium with a pharmaceutically acceptable carrier for the preparation of a medicament for preventing the initiation or progression of epithelial cancer.
Patent NZ-529663-A (NZ)
Title: Method for inhibiting calcium salt scale
Inventor: THOMPSON JACOB OWEN
IPC: D21C3/22
Filed: 2002-06-05
Abstract: Disclosed is a scale inhibiting composition for inhibiting calcium salt scale formation in alkaline aqueous mixtures of chemical pulping processes, said composition comprising the black liquor of said chemical pulping process and an effective scale inhibiting amount of at least one phosphonate selected from: Compounds having the formula (I):  M2-O-3P-CH2-N(R1)-(CH2)m-N(R2)-CH2PO3M2; Compounds having the formula (II):  R3-C(OH)(PO3M2)2; Compounds having the formula (III):  N-(CH2PO3M2)3; Compounds of formula (IV); or Amine oxides of formulae (I) and (III) wherein M is independently selected from H, alkali metal, alkaline earth metal and ammonium and the remaining substituents are as defined in the specification. Additionally disclosed are methods of inhibiting calcium salt scale comprising using the above compositions.
Patent NZ-533197-A (NZ)
Title: Waste disposal receptacle
Inventor: BUTLER RAYMOND THOMAS
IPC: B65F1/14
Filed: 2004-05-28
Abstract: A waste disposal receptacle (1) including a body (20) and a lid (30). The body is defined by a base (21), at least one side (22) and an open top (23); and the lid is defined by at least one side (31), a top (32) and an open base, and includes an aperture (35) in the at least one side through which material can be deposited into the receptacle. The at least one side of the lid is adapted to be received within the body and is reversibly movable between an open and closed position such that when the lid is in the closed position, the aperture is covered by the at least one side of the body, and when the lid is in the open position, the aperture is exposed.
Patent NZ-533441-A (NZ)
Title: Package having an inflated frame
Inventor: PALUMBO RICCARDO
IPC: B65D75/52
Filed: 2002-12-16
Abstract: A package (10) for containing a product (16) such as meat. The package includes top and bottom opposing flexible chamber sheets (18, 20). These sheets are sealed together in a selected chamber seal zone (22) to define a watertight chamber portion (12) that is capable of containing the product. A hollow frame (14) circumscribes the chamber portion. The frame supports the chamber portion when the frame is inflated. The need for a rigid tray may be eliminated by the package.
Patent NZ-533544-A (NZ)
Title: Novel peptide having angiotensin convertase inhibitory effect
Inventor: TAMURA YOSHITAKA
IPC: C07K5/083
Filed: 2002-11-21
Abstract: A peptide consisting of Methionine-Lysine-Proline (Met-Lys-Pro). Also disclosed is the use of a peptide consisting of Met-Lys-Pro in the production of a composition for the prophylaxis or treatment of hypotension.
Patent NZ-535861-A (NZ)
Title: Desmopressin acetate in an orodispersible dosage form that disintegrates in the mouth within 10 seconds
Inventor: NILSSON ANDERS
IPC: A61K38/095
Filed: 2003-05-07
Abstract: Good bioavailability of desmopressin can be obtained by means of an orodispersible pharmaceutical dosage form. Preferred dosage forms comprise desmopressin acetate in an open matrix network, which is an inert water-soluble or water-dispersible carrier material in a form adapted for sublingual administration. Desmopressin acetate formulated in this way is useful for voiding postponement, or the treatment or prevention of incontinence, primary nocturnal enuresis (PNE), nocturia or central diabetes insipidus. Peptides other than desmopressin can also be formulated in this way.
Patent NZ-537619-A (NZ)
Title: Interproximal brush with gargle and disinfectant
Inventor: HAN SANG-KEE
IPC: A45D34/04
Filed: 2003-06-13
Abstract: Disclosed herein is an interproximal brush with gargle and disinfectant. This interproximal brush includes two brush units. The brush units each include a handle having a rectangular cross-section, and an interproximal cleaning means, such as bristles or dental floss, fixed to an end of the handle. The interproximal brush also has a casing including two reception parts. In this case, the reception parts have a hollow box shape for receiving the brush units, and contain gargle and disinfectant therein, respectively. Further, a sealing unit is provided at a position around a mouth of each of the two reception parts. The two reception parts are integrated with each other to form a single structure, and are linearly arranged in a straight line or arranged parallel to each other in such a way that the mouths of the reception parts are opposite to each other or are adjacent to each other.
Patent NZ-538800-A (NZ)
Title: A laminate sheet for security booklets and method for making same
Inventor: ILIESCU IIIE
IPC: B42D15/00
Filed: 2005-03-11
Abstract: Disclosed is a hard laminate sheet for security booklets and method of making the same. The laminate sheet comprises at least two hard core layers (e.g. of polycarbonate) and a flexible component (e.g. nylon) there between and extending beyond an outer edge of the core layers to form a flexible band. The flexible component comprises a plurality of apertures within which material of the adjacent core layers is laminated together and affixes the flexible component to the laminate sheet. Additional hard core layers may be laminated to the core layers which sandwich the intermediate layer. Optionally, the laminate sheet may be used for a travel document (such as a passport) and may be laser engraved. Also, optionally, the laminate sheet may comprise a hard core inlay layer configured for containing a "contactless" integrated circuit chip and antenna or other electronic hardware.
Patent NZ-544273-A (NZ)
Title: Unique ballistic composition
Inventor: CUNNINGHAM DAVID VERLIN
IPC: F41H5/04
Filed: 2004-05-27
Abstract: A ballistic composite comprises multiple layers of a fabric having unidirectional ballistic resistant yarns in at least two layers and a resin layer between each pair of such multiple layers adhered to the ballistic resistant yarns but not encapsulation the same and not penetrating the layer of fabric. The ballistic yarn layers are at 90ø ñ 5ø with respect to each other and the ballistic resistant yarns are stabilized by being woven in a second fabric. The second fabric is formed of yarns having a substantially lower tenacity and tensile modulus than the ballistic resistant yarn. The ballistic resistant yarns have a tenacity of at least about 15 grams per denier and a modulus of at least about 40 grams per denier. The resin in the resin layer has a modulus of at least about 7000 psi.
Patent NZ-549011-A (NZ)
Title: Tricyclic imidazopyridines and intermediates for the synthesis thereof
Inventor: BUHR WILM
IPC: C07D471/14
Filed: 2005-02-10
Abstract: Disclosed is a tricyclic imidazopyridine compound of formulae (I) or (II), and salts thereof, with subtituents as disclosed in the specification. Also disclosed is the suitability of the above compound for treating and preventing gastrointestinal disorders. Also disclosed are processes for the synthesis of these compounds.
Patent NZ-549054-A (NZ)
Title: Chain wheel with a number of chain link pockets
Inventor: HSIEN-JUEY CHIU
Filed: 2006-08-08
Abstract: A chain wheel part comprising: a centre about which the part is adapted to rotate in use; and a plurality of chain link receiving pockets, wherein each pocket is bounded by a wall at first and second ends and is shaped such that a first end 20 of a chain link received in the pocket in use is nearer the centre of the chain wheel part than a second end 22 of the chain link.
Patent NZ-550818-A (NZ)
Title: TC-83-derived alphavirus vectors, particles and methods
Inventor: RAYNER JON O
IPC: C12N15/63
Filed: 2005-05-18
Abstract: Disclosed is an in vitro method for preparing Venezuelan equine encephalitis virus alphaviral replicon particles, said method comprising the steps of: (a) introducing an alphaviral replicon nucleic acid into a host cell, said alphavlral replicon nucleic acid comprising (i) a 5' sequence of Venezuelan equine encephalitis strain TC-83 which initiates transcription of alphavirus RNA, (ii) one or more nucleotide sequences which together encode those TC-83 alphavirus nonstructural proteins necessary for replication of the replicon RNA, (iii) a virus packaging signal, (iv) at least one heterologous coding or functional sequence expressible in said alphaviral replicon nucleic acid, and (v) a 3' RNA polymerase recognition sequence of Venezuelan equine encephalitis strain TC-83, wherein said host cell comprises at least one helper function encoding a TC-83 capsid protein and TC-83 glycoproteins, to produce a modified host cell; (b) culturing said modified host cell under conditions allowing expression of the at least one helper function, allowing replication of said alphaviral replicon nucleic acid and packaging of said alphaviral replicon nucleic acid to form alphaviral replicon particles.